Ophira Ginsburg: Many thanks to the incredible team at The Lancet for making this possible.
Ophira Ginsburg, shared a post by The Lancet, adding the following:
“Many thanks to the incredible team at The Lancet for making this possible. Especially our tireless editor Dr. Vania Wisdom Cancer Ambassador at The Lancet!
In case you missed it – the recording will be available soon. And please do check out our report. The executive summary is available in 8 languages!”
Quoting The Lancet’s post:
“Almost half of annual global cancer cases occur in women. Although women have around the same burden from all cancers combined, unequal power dynamics across society are negatively impacting how women interact with cancer prevention, care, and treatment.
‣ Discussions about cancer in women often narrowly focus on ‘women’s cancers’.
‣ Risk factors and causes of cancer in women are less understood than in men. At the same time, four identified major risk factors for cancer in women—tobacco and alcohol use, obesity, and infections—are widely under-recognised.
‣ Barriers to women’s professional advancement as leaders in the field contribute to a lack of women-centred cancer prevention and care.
‣ Women are more likely to have fewer financial resources to manage cancer-related financial challenges, and they typically bear unpaid caring responsibilities.
Of the 2.3 million women who die prematurely from cancer each year, 1.5 million lives could be saved through primary prevention or via early detection and diagnosis. A further 800,000 deaths could be prevented if all women everywhere had access to optimal cancer care.
To bring about transformation, a new Lancet Commission, led by Ophira Ginsburg, outlines recommendations to “advance an intersectional feminist approach”, and calls for sex and gender to be included in all cancer-related policies and guidelines.
The cancer system must become responsive to the needs and aspirations of all women—patients, care providers, and researchers.”
For details click here.
Source: Ophira Ginsburg/Twitter
Ophira Ginsburg is a Canadian medical oncologist, humanitarian, and global cancer advocate. Currently, she is the Senior Scientific Officer and Senior Advisor for Clinical Research at the US NCI’s Center for Global Health. Formerly based at the University of Toronto, Canada, she was a Medical Officer at the World Health Organization (WHO) Headquarters in Geneva, Switzerland, and has served as an ad hoc consultant to several UN agencies. She is the co-chair of The Lancet Commission on Women and Cancer. In 2022, Dr. Ginsburg won the American Society of Clinical Oncology’s Humanitarian Award.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023